Insulin-like growth factors inhibit dendritic cell-mediated anti-tumor immunity through regulating ERK1/2 phosphorylation and p38 dephosphorylation. [electronic resource]
Producer: 20150409Description: 117-26 p. digitalISSN:- 1872-7980
- Animals
- Antineoplastic Agents -- pharmacology
- Ascites -- metabolism
- Cell Line, Tumor
- Coculture Techniques
- Dendritic Cells -- drug effects
- Female
- Humans
- Immunity, Cellular -- drug effects
- Insulin-Like Growth Factor I -- genetics
- Insulin-Like Growth Factor II -- genetics
- Interferon-gamma -- metabolism
- Interleukins -- metabolism
- Lymphocyte Activation
- Mice, Inbred C57BL
- Mitogen-Activated Protein Kinase 1 -- metabolism
- Mitogen-Activated Protein Kinase 3 -- metabolism
- Neoplasm Staging
- Ovarian Neoplasms -- drug therapy
- Phosphorylation
- Pyrimidines -- pharmacology
- Pyrroles -- pharmacology
- Receptor, IGF Type 1 -- antagonists & inhibitors
- Signal Transduction
- T-Lymphocytes, Cytotoxic -- immunology
- Time Factors
- Transfection
- Tumor Necrosis Factor-alpha -- metabolism
- p38 Mitogen-Activated Protein Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.